Southampton Healthcare, Inc.
1 clinical trials · Sponsor
◉ Watch Southampton Healthcare, Inc.
| Record | Firm | Date |
|---|---|---|
| Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy (NCT04040075) | Southampton Healthcare, Inc. | 2019-07-01 |
Track Southampton Healthcare, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.